Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 174Unknown 142Recruiting 77Terminated 47Not yet recruiting 26Active not recruiting 22Withdrawn 18Enrolling by invitation 2Suspended 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Inflammation 1Breast Neoplasms 1

Interventions

Cisplatin 9Specimen Handling 7Educational Status 7Standard of Care 6Interviews as Topic 6Drug Therapy 6Carboplatin 6Blood Specimen Collection 6Radiotherapy 5Nivolumab 5Chemoradiotherapy 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Paclitaxel 4Oxaliplatin 4Observation 4Lenalidomide 4Fluorouracil 4Fluorodeoxyglucose F18 4Dexamethasone 4pembrolizumab 3lenvatinib 3camrelizumab 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Gemcitabine 3Exercise 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enrolling by invitation × Neoadjuvant Therapy × Clear all
NCT06447532 2025-03-12

INFLAMMATE

Federal University of São Paulo

Enrolling by invitation
4,500 enrolled
Breast

Breast Neoplasms, Inflammation

NCT06714084 2024-12-03

CNCMT

Hubei Cancer Hospital

Phase NA Enrolling by invitation
20 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡